XTX Topco Ltd Acquires New Shares in HealthEquity, Inc. (NASDAQ:HQY)

XTX Topco Ltd bought a new position in HealthEquity, Inc. (NASDAQ:HQY) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 4,500 shares of the company’s stock, valued at approximately $432,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Barclays PLC lifted its stake in shares of HealthEquity by 209.3% in the 3rd quarter. Barclays PLC now owns 166,492 shares of the company’s stock valued at $13,628,000 after purchasing an additional 112,667 shares during the last quarter. Sanctuary Advisors LLC bought a new stake in shares of HealthEquity during the 3rd quarter worth about $260,000. Wilmington Savings Fund Society FSB acquired a new position in shares of HealthEquity during the 3rd quarter valued at about $150,000. Franklin Resources Inc. lifted its holdings in HealthEquity by 0.7% in the 3rd quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company’s stock worth $139,369,000 after purchasing an additional 11,659 shares during the last quarter. Finally, GAMMA Investing LLC boosted its position in HealthEquity by 32.9% during the fourth quarter. GAMMA Investing LLC now owns 1,248 shares of the company’s stock worth $120,000 after purchasing an additional 309 shares during the period. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Stock Down 5.1 %

Shares of HQY opened at $80.20 on Tuesday. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a 50-day moving average price of $94.09 and a two-hundred day moving average price of $96.53. The stock has a market cap of $6.94 billion, a price-to-earnings ratio of 73.58, a P/E/G ratio of 1.60 and a beta of 0.49. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59.

Analyst Ratings Changes

HQY has been the subject of a number of analyst reports. Barrington Research restated an “outperform” rating and issued a $112.00 price objective on shares of HealthEquity in a research note on Friday, April 11th. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and lowered their price target for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. The Goldman Sachs Group decreased their target price on HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a research note on Thursday, March 27th. Wells Fargo & Company upped their price target on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Finally, KeyCorp cut their target price on shares of HealthEquity from $110.00 to $100.00 and set an “overweight” rating for the company in a research note on Wednesday, April 16th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, HealthEquity currently has an average rating of “Buy” and an average price target of $111.75.

Insider Transactions at HealthEquity

In other news, EVP Michael Henry Fiore sold 8,881 shares of the business’s stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the transaction, the executive vice president now directly owns 56,655 shares of the company’s stock, valued at $4,433,820.30. The trade was a 13.55 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the sale, the director now directly owns 84,969 shares of the company’s stock, valued at $6,597,842.85. This represents a 6.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 20,381 shares of company stock valued at $1,781,432. Corporate insiders own 2.20% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.